3H,4H-thieno[2,3-d]pyrimidin-4-one derivatives as TRPA1 inhibitors

Abstract

The present disclosure provides certain 3H,4H-thieno[2,3-d]pyrimidin-4-one derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.

Dependencies are inferred from the claim text.